ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2019 and some content may be unavailable. To unlock all content for 2019, please visit the archives.

Abstract: FR-PO318

The KDIGO 2012 CKD Classification System Improves Physician Recognition and Management of Kidney Disease: A Randomized Vignette Study

Session Information

Category: CKD (Non-Dialysis)

  • 2102 CKD (Non-Dialysis): Clinical, Outcomes, and Trials

Authors

  • Hallan, Stein I., NTNU, Trondheim, Norway
  • Rifkin, Dena E., UCSD, San Diego, California, United States
  • Potok, O. Alison, UCSD, San Diego, California, United States
  • Langlo, Knut Asbjørn Rise, St. Olavs Hospital HF, Trondheim, Norway
  • Dekker, Friedo W., Leiden University Medical Center, Leiden, Netherlands
  • Ix, Joachim H., UCSD, San Diego, California, United States
Background

Chronic kidney disease (CKD) is common worldwide with high morbidity and mortality rates. New international guidelines based on estimated glomerular filtration rate (eGFR) versus albuminuria were introduced 2012 to help with diagnosis, classification, referral, and treatment, but their clinical utility has not been evaluated. We therefore wanted to determine if KDIGO guideline helps physicians recognize and appropriately care for CKD patients.

Methods

We conducted a randomized vignette experiment with fractional factorial design based on 6 kidney-related scenarios and 3 laboratory presentation methods reflecting the KDIGO guideline. Participants evaluated one of three subsets of the 18 vignettes (i.e. 6 vignettes each with 4 answer alternatives). Kidney related results (serum creatinine and urine albumin) were presented as the “Old” (high/low levels), “Modern” (eGFR reported automatically), or “Future” (eGFR + albuminuria categorization + risk for complications = full 2012 KDIGO classification) laboratory report. Logistic regression modelled correct CKD management with laboratory presentation technique, clinical scenario, and other physician covariates. We included 249 interns, general practitioners, and residents/fellows from Norway and the US participating in post-graduate meetings and courses provided to physicians in training.

Results

When kidney laboratory data was presented as the “Modern report” (automatic eGFR calculation), there was a significantly higher probability for correct patient management compared to the “Old report” (OR 1.57, p<0.0001). Additional significant improvement was obtained with the “Future report” (OR 2.28 for correct answer, p<0.001 vs. “Old report”; OR 1.45, p=0.005 vs. “Modern report”). The 2012 KDIGO classification system improved physician management in 4 of the 6 clinical scenarios covering a wide range of kidney-related topics. Interaction analysis showed that GPs and those with 1-3 years of internal medicine experience had the strongest improvements with the new presentation techniques

Conclusion

Automatic GFR estimation, albuminuria categorization, and notification of the associated risk for complications improve most physicians` recognition and management of a wide range of CKD clinical scenarios.

Funding

  • Government Support - Non-U.S.